Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Cash & Current Investments: 2009-2025

Historic Cash & Current Investments for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $145.0 million.

  • BIO-TECHNE's Cash & Current Investments fell 25.36% to $145.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $631.4 million, marking a year-over-year decrease of 2.78%. This contributed to the annual value of $165.0 million for FY2025, which is 2.12% up from last year.
  • As of Q3 2025, BIO-TECHNE's Cash & Current Investments stood at $145.0 million, which was down 12.16% from $165.0 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Cash & Current Investments peaked at $279.0 million during Q4 2021, and registered a low of $140.7 million during Q1 2025.
  • For the 3-year period, BIO-TECHNE's Cash & Current Investments averaged around $164.4 million, with its median value being $161.6 million (2024).
  • Per our database at Business Quant, BIO-TECHNE's Cash & Current Investments plummeted by 32.00% in 2023 and then climbed by 27.56% in 2024.
  • Over the past 5 years, BIO-TECHNE's Cash & Current Investments (Quarterly) stood at $279.0 million in 2021, then decreased by 29.47% to $196.8 million in 2022, then declined by 27.97% to $141.7 million in 2023, then climbed by 27.56% to $180.8 million in 2024, then dropped by 25.36% to $145.0 million in 2025.
  • Its Cash & Current Investments stands at $145.0 million for Q3 2025, versus $165.0 million for Q2 2025 and $140.7 million for Q1 2025.